Article
Polymorphisms in immune mediators associate with risk of cervical cancer.
Gynecologic oncology - 1 Oct 2014
Zhang Zhengyan, Fye Samantha, Borecki Ingrid B, Rader Janet S
Abstract excerpt
OBJECTIVE: The immune system is critical for controlling the progression of HPV cervical disease and the development of cancer. This study aimed to identify cervical cancer susceptibility alleles in candidate immune-modulating genes. METHODS: Our family-based study involved a cohort of 641 probands (women with ICC/CIN III) and their biologic parents or siblings (641 trios). In the discovery phase (stage 1),...
Topics
- Adult
- Female
- Genetic Association Studies
- Humans
- Immunologic Factors
- Polymorphism, Single Nucleotide
- Risk Factors
- Uterine Cervical Neoplasms
